Related Experiment Videos
Molecular biology of gynecologic malignancies
T C Hamilton1, S W Johnson, A K Godwin
1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Cancer Treatment and Research
|June 10, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Cellular stemness identifies high-risk ductal carcinoma in situ and offers a therapeutic interception opportunity.
bioRxiv : the preprint server for biology·2026
Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313).
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Cure with ledipasvir/sofosbuvir for chronic hepatitis C virus in an individual with gastric bypass.
Journal of clinical pharmacy and therapeutics·2017
Curing the historically incurable: treatment success with ledipasvir/sofosbuvir for chronic hepatitis C virus in a heavily treatment-experienced individual.
Journal of clinical pharmacy and therapeutics·2016
Clinical Trials and Translational Advances in Metabolic Targeting.
Cancer treatment and research·2026
Tools and Technologies for Studying Cancer Metabolism.
Cancer treatment and research·2026
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.
Cancer treatment and research·2026
Biomarkers of Cancer Metabolism and Therapeutic Response.
Cancer treatment and research·2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.
Cancer treatment and research·2026
Metabolic Reprogramming in Cancer Stem Cells.
Cancer treatment and research·2026